Clinical Trial Update: Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a weight management program to mitigate weight gain in patients with schizophrenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenic Disorders | Phase 4 | Status: COMPLETED